Sangamo Therapeutics, Inc. (SGMO)

USD 2.35

(-16.67%)

Annual Balance Sheets

(In USD)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 165.32 Million 562.5 Million 721.92 Million 938.55 Million 637.51 Million 590.39 Million
Total Current Assets 94.32 Million 300.32 Million 398.76 Million 659.66 Million 405.47 Million 410.52 Million
Cash And Short Term Investments 81 Million 277.63 Million 464.71 Million 691.95 Million 384.98 Million 400.5 Million
Cash and Cash Equivalents 45.2 Million 100.44 Million 178.87 Million 131.32 Million 80.42 Million 140.41 Million
Short Term Investments 35.79 Million 177.18 Million 197.67 Million 510.09 Million 282.04 Million 259.71 Million
Net Receivables 1.32 Million 4.47 Million 6.36 Million 6.25 Million 37.59 Million 5.04 Million
Inventory - 1.00 -88.16 Million -50.53 Million -22.51 Million -375 Thousand
Other Current Assets 12 Million 18.22 Million 15.85 Million 11.98 Million 5.4 Million 5.34 Million
Total Non-Current Assets 70.99 Million 262.18 Million 323.15 Million 278.88 Million 232.04 Million 179.87 Million
Net PPE 52.86 Million 125.53 Million 124.7 Million 112.36 Million 107.21 Million 78.72 Million
Good Will And Intangible Assets - 88.28 Million 93.46 Million 100.92 Million 92.42 Million 94.91 Million
Good Will - 37.55 Million 39.7 Million 42.79 Million 39.27 Million 40.04 Million
Intangible Assets - 50.72 Million 53.76 Million 58.12 Million 53.15 Million 54.86 Million
Long-Term Investments 1.5 Million 29.84 Million 88.16 Million 50.53 Million 21.83 Million -6.7 Million
Tax Assets - 6.27 Million 6.64 Million 7.18 Million 6.57 Million 6.7 Million
Other Non Current Assets 16.62 Million 12.25 Million 10.17 Million 7.87 Million 3.99 Million 6.24 Million
Other Assets 1.00 - - - - -
Total Liabilities 82.43 Million 267.55 Million 346.58 Million 441.18 Million 204.77 Million 223.87 Million
Total Current Liabilities 47.73 Million 111.71 Million 127.88 Million 143.54 Million 69.87 Million 78.51 Million
Account Payables 15.25 Million 22.41 Million 9.75 Million 12.55 Million 6.67 Million 3.35 Million
Tax Payables - - - - - -
Short Term Debt 4.58 Million 4.12 Million 4.02 Million 3.69 Million 3.21 Million -
Deferred Revenue - 51.78 Million 85.71 Million 96.64 Million 38.71 Million 47.56 Million
Other Current Liabilities 27.88 Million 33.39 Million 28.39 Million 30.66 Million 21.27 Million 27.59 Million
Total Non Current Liabilities 34.7 Million 155.84 Million 218.69 Million 297.63 Million 134.9 Million 144.62 Million
Long-Term Debt 33.51 Million 38.98 Million 44.05 Million 38.39 Million 41.19 Million 27.68 Million
Deferred Revenue Non Current - 109.37 Million 166.77 Million 245.04 Million 81.43 Million 108.27 Million
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 1.18 Million 1.2 Million 1.21 Million 7.01 Million 5.71 Million 1.96 Million
Other Liabilities - - - - - 739 Thousand
Total Equity 82.88 Million 294.95 Million 375.34 Million 496.49 Million 432.92 Million 367.25 Million
Stock Holders Equity 82.88 Million 294.95 Million 375.34 Million 497.36 Million 432.73 Million 366.51 Million
Common Stock 1.78 Million 1.66 Million 1.45 Million 1.42 Million 1.16 Million 1.02 Million
Retained Earnings -1.4 Billion -1.14 Billion -956.26 Million -777.98 Million -656.98 Million -562.69 Million
Accumulated other comprehensive income -4.59 Million -8.4 Million -3.98 Million 5.41 Million -2.44 Million -1.44 Million
Common Stock Equity 82.88 Million 294.95 Million 375.34 Million 497.36 Million 432.73 Million 366.51 Million
Capital Lease Obligation 33.51 Million 43.1 Million 48.08 Million 42.08 Million 44.4 Million 27.68 Million
Total Investments 37.29 Million 207.03 Million 285.84 Million 560.62 Million 303.87 Million 259.71 Million
Total Debt 38.1 Million 43.1 Million 48.08 Million 42.08 Million 44.4 Million 27.68 Million
Net Debt -7.1 Million -57.33 Million -130.79 Million -89.24 Million -36.02 Million -112.72 Million

Balance Sheet Charts